Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy

F Wang, J Guan - Advanced drug delivery reviews, 2010 - Elsevier
Heart diseases, including myocardial infarction (MI) and congestive heart failure (CHF),
have high mortality rates. Both MI and CHF are characterized by cardiac muscle damage …

From stem cells and cadaveric matrix to engineered organs

DA Taylor - Current opinion in biotechnology, 2009 - Elsevier
The definitive treatment for end-stage heart failure, organ transplant, is limited by the supply
of donor organs. Successful allograft recipients suffer significant adverse effects from chronic …

Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts

EL Olivares, VP Ribeiro… - American Journal …, 2004 - journals.physiology.org
Postinfarct congestive heart failure is one of the leading causes of morbidity and mortality in
developed and developing countries. The main purpose of this study was to investigate …

Intrakoronare, humane autologe Stammzelltransplantation zur Myokardregeneration nach Herzinfarkt

BE Strauer, M Brehm, T Zeus… - DMW-Deutsche …, 2001 - thieme-connect.com
Hintergrund: Das regenerative Potential humaner autologer adulter Stammzellen auf die
Kardiomyogenese und Angiogenese nach Herzinfarkt könnte zur Infarktheilung beitragen …

Coronary heart disease in the first 30 years of the 21st century: challenges and opportunities: The 33rd Annual James B. Herrick Lecture of the Council on Clinical …

GA Beller - Circulation, 2001 - Am Heart Assoc
During the past 50 years, there has been an explosion of new knowledge regarding the
biological mechanisms of cardiovascular disease. This knowledge and the emergence of …

Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications

E Abdelwahid, T Siminiak… - Current cardiology …, 2011 - ingentaconnect.com
Degeneration of cardiac tissues is considered a major cause of mortality in the western
world and is expected to be a greater problem in the forthcoming decades. Cardiac damage …

Myocardial replacement therapy

T Siminiak, M Kurpisz - Circulation, 2003 - Am Heart Assoc
1167 in this area confirm that, depending on the specific microenvironment, ESCs may
mature and acquire all the characteristics of the target tissue. The instrumentation of ESC …

Cell-based myocardial repair: how should we proceed?

DA Taylor - International journal of cardiology, 2004 - Elsevier
Cell-based myocardial repair and regeneration heralds a new frontier in the treatment of
cardiovascular disease. It provides an unprecedented opportunity to treat the underlying …

Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure

DA Taylor - Trials, 2001 - Springer
Cell transplantation to repair or regenerate injured myocardium is a new frontier in the
treatment of cardiovascular disease. Even though it is based on many years of pre-clinical …

Myocardial regeneration after intracoronary transplantation of human autologous stem cells following acute myocardial infarction

BE Strauer, M Brehm, T Zeus… - DMW-Deutsche …, 2001 - thieme-connect.com
Hintergrund: Das regenerative Potential humaner autologer adulter Stammzellen auf die
Kardiomyogenese und Angiogenese nach Herzinfarkt könnte zur Infarktheilung beitragen …